{"id":404587,"date":"2020-12-22T10:02:55","date_gmt":"2020-12-22T15:02:55","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=404587"},"modified":"2020-12-22T10:02:55","modified_gmt":"2020-12-22T15:02:55","slug":"caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\/","title":{"rendered":"CareDx Celebrates the Long-Awaited Passage of the Immuno Bill"},"content":{"rendered":"<h2>\nPartners with large transplant coalition to expand access to lifesaving medications for kidney transplant patients<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>SOUTH SAN FRANCISCO, Calif., Dec.  22, 2020  (GLOBE NEWSWIRE) &#8212; CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, applauds Congress on today\u2019s passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019 (Immuno Bill).<\/p>\n<p>Immunosuppressive medication compliance is a critical component of the long-term success of any kidney transplant. This bipartisan legislation will extend Medicare\u2019s Part B coverage of immunosuppressive drugs for kidney transplant recipients beyond the current three-year limit, allowing patients to more easily maintain access to their treatment and prevent graft failure, costly dialysis treatments, and retransplantation.<\/p>\n<p>\u201cOur fight to ensure the Immuno Bill was passed during this Congress is an extension of CareDx\u2019s mission to improve the long term outcomes of patients,\u201d said Peter Maag, Executive Chairman of CareDx. \u201cThis landmark victory is a testament to our close collaboration with the transplant ecosystem and the advocacy of dedicated patients and physicians around the country who made their voices heard along the way.\u201d<\/p>\n<p>In March 2019, driven by our dedication to serving patients and caregivers, CareDx launched the Honor the Gift Coalition \u2013 a national patient-centered campaign focused on rallying the kidney community for the passage of the Immuno Bill.<\/p>\n<p>With 32 member organizations across the transplant space, including the National Kidney Foundation, the American Society of Transplant Surgeons, and Donate Life America, the Honor the Gift Coalition successfully united and encouraged nearly 10,000 advocates from all 50 states to write their legislators and demand their support for this critical legislation.<\/p>\n<p>\u201cImmunosuppression medication coverage reforms are long overdue and I could not be more thankful to all those who helped make it possible,\u201d said Mary Baliker, patient advocate and four-time kidney transplant recipient from Wisconsin. \u201cI know what it\u2019s like to wonder how you\u2019re going to afford your anti-rejection medications at the end of the month\u2014passing the Immuno Bill means that patients will get to breathe a little easier once the law is enacted.\u201d<\/p>\n<p>\u201cMedicare\u2019s limitation on immunosuppressive drug coverage was never able to be justified medically, economically or ethically, and I am thankful Congress has finally taken action on this much-needed reform,\u201d said Marwan S. Abouljoud, MD, FACS, MMM, president of the American Society of Transplant Surgeons. \u201cThe American Society of Transplant Surgeons is proud to stand with CareDx and the entire Honor the Gift Coalition as we celebrate the correction of this long-standing, short-sighted policy.\u201d<\/p>\n<p>To learn more about CareDx\u2019s work to extend Medicare coverage of immunosuppressive medications for kidney transplant recipients, visit HonorTheGift.org.<\/p>\n<p>\n        <strong>About\u00a0CareDx<\/strong>\n      <\/p>\n<p>CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Jfaa_XwsfgijDPwVAkqhyKQofhnfIxfDbQB4-Z6-JGLW8ZS9QZ0_c0e5piJKwm2fnXb_K21UWQW_9k8IsX4bLQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.CareDx.com<\/a>.<\/p>\n<p>\n        <strong>CONTACTS:<\/strong>\n      <\/p>\n<p>Sasha King<br \/>Chief Marketing Officer<br \/>415-287-2393<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wtm2E3mPOFqrwFV3QZJCV3IhxRIarL71UN4PKGEUXCncESTUzBBRyLI9NnpFy31K7VxMFn1Oa10mVJzQtJLwzA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">sking@caredx.com<\/a>\u00a0<\/p>\n<p>Investor Relations<br \/>Greg Chodaczek<br \/>347-620-7010<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=T3Ia1Me_wrocskvVmE3INYDsUyIfqVCpiHmsN0LVS2uMZN1o86uLXsIN7v8W8qj4MVfU7aMpoItI7KNGc5_485ShSTsDjocze-rLQedIHCs=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">investor@caredx.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNjUxOSMzODkzMjg5IzIwMDQ1MDM=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/f11fcf18-1fa2-42c6-bf5b-825e4c73d41d\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Partners with large transplant coalition to expand access to lifesaving medications for kidney transplant patients SOUTH SAN FRANCISCO, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) &#8212; CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, applauds Congress on today\u2019s passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019 (Immuno Bill). Immunosuppressive medication compliance is a critical component of the long-term success of any kidney transplant. This bipartisan legislation will extend Medicare\u2019s Part B coverage of immunosuppressive drugs for kidney transplant recipients beyond the current three-year limit, allowing patients to more easily maintain access to their treatment and prevent &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;CareDx Celebrates the Long-Awaited Passage of the Immuno Bill&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-404587","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CareDx Celebrates the Long-Awaited Passage of the Immuno Bill - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CareDx Celebrates the Long-Awaited Passage of the Immuno Bill - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Partners with large transplant coalition to expand access to lifesaving medications for kidney transplant patients SOUTH SAN FRANCISCO, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) &#8212; CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, applauds Congress on today\u2019s passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019 (Immuno Bill). Immunosuppressive medication compliance is a critical component of the long-term success of any kidney transplant. This bipartisan legislation will extend Medicare\u2019s Part B coverage of immunosuppressive drugs for kidney transplant recipients beyond the current three-year limit, allowing patients to more easily maintain access to their treatment and prevent &hellip; Continue reading &quot;CareDx Celebrates the Long-Awaited Passage of the Immuno Bill&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-22T15:02:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNjUxOSMzODkzMjg5IzIwMDQ1MDM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CareDx Celebrates the Long-Awaited Passage of the Immuno Bill\",\"datePublished\":\"2020-12-22T15:02:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\\\/\"},\"wordCount\":544,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNjUxOSMzODkzMjg5IzIwMDQ1MDM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\\\/\",\"name\":\"CareDx Celebrates the Long-Awaited Passage of the Immuno Bill - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNjUxOSMzODkzMjg5IzIwMDQ1MDM=\",\"datePublished\":\"2020-12-22T15:02:55+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNjUxOSMzODkzMjg5IzIwMDQ1MDM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNjUxOSMzODkzMjg5IzIwMDQ1MDM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CareDx Celebrates the Long-Awaited Passage of the Immuno Bill\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CareDx Celebrates the Long-Awaited Passage of the Immuno Bill - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\/","og_locale":"en_US","og_type":"article","og_title":"CareDx Celebrates the Long-Awaited Passage of the Immuno Bill - Market Newsdesk","og_description":"Partners with large transplant coalition to expand access to lifesaving medications for kidney transplant patients SOUTH SAN FRANCISCO, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) &#8212; CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, applauds Congress on today\u2019s passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019 (Immuno Bill). Immunosuppressive medication compliance is a critical component of the long-term success of any kidney transplant. This bipartisan legislation will extend Medicare\u2019s Part B coverage of immunosuppressive drugs for kidney transplant recipients beyond the current three-year limit, allowing patients to more easily maintain access to their treatment and prevent &hellip; Continue reading \"CareDx Celebrates the Long-Awaited Passage of the Immuno Bill\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-22T15:02:55+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNjUxOSMzODkzMjg5IzIwMDQ1MDM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CareDx Celebrates the Long-Awaited Passage of the Immuno Bill","datePublished":"2020-12-22T15:02:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\/"},"wordCount":544,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNjUxOSMzODkzMjg5IzIwMDQ1MDM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\/","name":"CareDx Celebrates the Long-Awaited Passage of the Immuno Bill - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNjUxOSMzODkzMjg5IzIwMDQ1MDM=","datePublished":"2020-12-22T15:02:55+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNjUxOSMzODkzMjg5IzIwMDQ1MDM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNjUxOSMzODkzMjg5IzIwMDQ1MDM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-celebrates-the-long-awaited-passage-of-the-immuno-bill\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CareDx Celebrates the Long-Awaited Passage of the Immuno Bill"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/404587","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=404587"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/404587\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=404587"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=404587"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=404587"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}